
Investor Relations
Symbol:
PRICE: $00.00
DIVIDEND: $.00
CHANGE: 0.00%
Latest News
February 15, 2027

Upcoming Events
November 25, 2027
November 25, 2027
Projected
Reportable Segments

Wellness & Nutrition
Vitatherx®, NattyLean®
Projected Revenue Mix: 40%
Skincare & Clinical
Skintherx®, Blk Lbl Skn®, Clintherx®
Projected Revenue Mix: 35%
Digital Health & Tech
MyCure.MD®, Oprine®, Aoxing BioPharmaceutical®
Projected Revenue Mix: 25%
Revenue
Customer Segmentation
Revenue
Geography
Consumer


Business
Institution
Investor
Europe
North America
Asia
Symbol:
PRICE: $00.00
DIVIDEND: $.00
CHANGE: 0.00%
Latest News
February 15, 2027

Upcoming Events
November 25, 2027
November 25, 2027
Latest Annual Highlights
2
Continents
2
$10M
Operational in multiple continents:
North America, Europe,
Publicly traded product pending approvals
Preferred stock value scheduled for global exchanges

R&D Pipeline
ABOUT AOXING
3
Phase I
7
PROGRAMS IN DEVELOPMENT
MOST ADVANCED PROGRAM
BRAND ENTITIES
THERAPEUTIC FOCUS AREAS
2
- Programs in development3
- Most advanced programPhase 3
- Brand entities7
- Therapeutic focus areas2
PROGRAMS IN DEVELOPMENT
MOST ADVANCED PROGRAM
BRAND ENTITIES
THERAPEUTIC FOCUS AREAS
3
Phase I
7
2
Aoxing BioPharmaceutical brings together a portfolio of wellness, care, and rejuvenation brands engineered to help people feel their best every day. From daily wellness and natural care to revitalizing self-care experiences, our family of brands delivers a unique range of high-quality products and services built around real ingredients and real results.
Helping people feel their best is our passion; it drives us to collaborate, develop, and research products and programs that help our clients achieve sustainable and consistent results. Whether you are refreshing your daily routine, exploring new wellness and care options, or building a healthier lifestyle for yourself and your family, our innovative products and services provide the solutions you need to feel your best every day.


